404 related articles for article (PubMed ID: 10384922)
1. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
4. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
Bräutigam M
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
[TBL] [Abstract][Full Text] [Related]
6. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Heikkilä H; Stubb S
Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
[TBL] [Abstract][Full Text] [Related]
7. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
8. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
9. Oral antifungal medication for toenail onychomycosis.
Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
[TBL] [Abstract][Full Text] [Related]
10. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
11. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
[TBL] [Abstract][Full Text] [Related]
12. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Evans EG; Sigurgeirsson B
BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Jansen R; Redekop WK; Rutten FF
Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
[TBL] [Abstract][Full Text] [Related]
14. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
[TBL] [Abstract][Full Text] [Related]
15. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
16. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Bräutigam M; Nolting S; Schopf RE; Weidinger G
Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
[TBL] [Abstract][Full Text] [Related]
17. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Tosti A; Piraccini BM; Stinchi C; Colombo MD
Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
Jones HE; Zaias N
Int J Dermatol; 1996 Aug; 35(8):589-90. PubMed ID: 8854164
[No Abstract] [Full Text] [Related]
19. Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
Arenas R; Domínguez-Cherit J; Fernández LM
Int J Dermatol; 1995 Feb; 34(2):138-43. PubMed ID: 7737776
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Safer LF
Acta Derm Venereol; 2000; 80(4):317-8. PubMed ID: 11028880
[No Abstract] [Full Text] [Related]
[Next] [New Search]
